Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital.

Jamaati H, Dastan F, Mirshafiei Langari Z, Haghgoo R, Eskandari R, Marjani M, Moniri A, Hashemian SM, Farzanegan B, Abedini A, Tabarsi P, Velayati AA.

Tanaffos. 2018 Mar;17(3):183-187.

2.

Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex.

Hedayati MT, Tavakoli M, Maleki M, Heidari S, Mortezaee V, Gheisari M, Hassanzad M, Mirenayat MS, Mahdaviani SA, Pourabdollah M, Velayati AA, Vakili M, Abastabar M, Haghani I, Jafarzadeh J, Hedayati N, Seyedmousavi S, Alastruey-Izquierdo A.

Microb Pathog. 2019 Apr;129:168-175. doi: 10.1016/j.micpath.2019.02.009. Epub 2019 Feb 8.

PMID:
30742949
3.

CT-measured pulmonary artery diameter as an independent predictor of pulmonary hypertension in cystic fibrosis.

Bakhshayeshkaram M, Aghahosseini F, Vaezi F, Kahkooei S, Salehi Y, Hassanzad M, Jamaati HR, Velayati AA.

Pol J Radiol. 2018 Aug 23;83:e401-e406. doi: 10.5114/pjr.2018.79204. eCollection 2018.

4.

Reappraisal of Frequency of Common Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Iranian Cystic Fibrosis Patients.

Khalilzadeh S, Hassanzad M, PourAbdollah Toutkaboni M, Tashayoie Nejad S, Sheikholeslami FM, Velayati AA.

Tanaffos. 2018 Feb;17(2):73-81.

5.

TNFα -857 C/T and TNFR2 +587 T/G polymorphisms are associated with cystic fibrosis in Iranian patients.

Hassanzad M, Farnia P, Ghanavi J, Parvini F, Saif S, Velayati AA.

Eur J Med Genet. 2018 Nov 22. pii: S1769-7212(18)30327-6. doi: 10.1016/j.ejmg.2018.11.018. [Epub ahead of print]

PMID:
30472484
6.

Pulmonary Function and Hospital Admission in Patients with Cystic Fibrosis Based on Household Second-Hand Smoking.

Hassanzad M, Eslampanah S, Modaresi M, Tashayoie-Nejad S, Velayati AA.

Tanaffos. 2018 Jan;17(1):37-41.

7.

Good's Syndrome-Association of the Late Onset Combined Immunodeficiency with Thymoma: Review of Literature and Case Report.

Tavakol M, Mahdaviani SA, Ghaemi MR, Vaezi M, Dorudinia A, Jamaati H, Velayati AA.

Iran J Allergy Asthma Immunol. 2018 Feb;17(1):85-93.

8.

An Iranian Consensus Document for Nutrition in Critically Ill Patients, Recommendations and Initial Steps toward Regional Guidelines.

Hashemian SM, Martindale RG, Jamaati H, Amirsavadkouhi A, Mahmudi Azer S, Shadnoush M, Ardehali SH, Najafi A, Ahmadi A, Seyyedi SR, Mahmoodpoor A, Moradi O, Abbasi S, Hosseini S, Shahrami R, Abdi S, Sepehri Z, Omranirad B, Mohajerani SA, Rohani P, Sayyari A, Imani H, Velayati AA.

Tanaffos. 2017;16(2):89-98. Review. No abstract available.

9.

Drug-resistant Mycobacterium tuberculosis: Epidemiology and role of morphological alterations.

Velayati AA, Farnia P, Hoffner S.

J Glob Antimicrob Resist. 2018 Mar;12:192-196. doi: 10.1016/j.jgar.2017.10.006. Epub 2017 Oct 16. Review.

PMID:
29042338
10.

Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years.

Baghaei P, Tabarsi P, Moniri A, Marjani M, Farnia P, Jabbehdari S, Velayati AA.

J Glob Antimicrob Resist. 2017 Dec;11:116-119. doi: 10.1016/j.jgar.2017.06.010. Epub 2017 Jul 21.

PMID:
28739225
11.

Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease.

Farnia P, Ghanavi J, Saif S, Farnia P, Velayati AA.

Am J Trop Med Hyg. 2017 Jul;97(1):57-61. doi: 10.4269/ajtmh.16-0905.

12.

Modified rifampin nanoparticles: Increased solubility with slow release Rate.

Farnia P, Velayati AA, Mollaei S, Ghanavi J.

Int J Mycobacteriol. 2017 Apr-Jun;6(2):171-176. doi: 10.4103/ijmy.ijmy_21_17.

13.

Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.

Sharif A, Aghakhani A, Velayati AA, Banifazl M, Sharif MR, Razeghi E, Kheirkhah D, Kazemimanesh M, Bavand A, Ramezani A.

Intervirology. 2016;59(3):179-185. doi: 10.1159/000455124. Epub 2017 Feb 1.

14.

Comparison of single nucleotide polymorphisms [SNP] at TNF-α promoter region with TNF receptor 2 (TNFR2) in susceptibility to pulmonary tuberculosis; using PCR-RFLP technique.

Ghamari E, Farnia P, Saif S, Marashian M, Ghanavi J, Farnia P, Velayati AA.

Am J Clin Exp Immunol. 2016 Nov 30;5(4):55-61. eCollection 2016.

15.

Radiographic manifestations of Tuberculosis in HIV positive patients: Correlation with CD4+ T-cell count.

Bakhshayesh-Karam M, Tabarsi P, Mirsaiedi SM, Amiri MV, Zahirifard S, Mansoori SD, Masjedi MR, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S244-S245. doi: 10.1016/j.ijmyco.2016.11.027. Epub 2016 Dec 5.

16.

Mediastinal lymphadenopathy in pediatric tuberculosis in computed tomography scan.

Mehrain P, Moghaddam AM, Tavakol E, Amini A, Moghimi M, Kabir A, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S242-S243. doi: 10.1016/j.ijmyco.2016.11.019. Epub 2016 Nov 25.

17.

Deletion of region of difference 181 in Mycobacterium tuberculosis Beijing strains.

Sharifipour E, Farnia P, Mozafari M, Irani S, Akbar Velayati A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S238-S239. doi: 10.1016/j.ijmyco.2016.09.071. Epub 2016 Nov 25.

18.

Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae.

Farnia P, Malekshahian D, Tabarsi P, Seif S, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S215. doi: 10.1016/j.ijmyco.2016.11.006. Epub 2016 Nov 22.

19.

Identification of different subtypes of rapid growing Atypical Mycobacterium from water and soil sources: Using PCR-RFLP using hsp65 and rRNA 16s-23s genes.

Varahram M, Farnia P, Saif S, Marashian M, Farnia P, Ghanavi J, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S212-S213. doi: 10.1016/j.ijmyco.2016.09.057. Epub 2016 Nov 14.

20.

The importance of single nucleotide polymorphisms in interferon gamma receptor-1 gene in pulmonary patients infected with rapid grower mycobacterium.

Farnia P, Ghanavi J, Tabasri P, Saif S, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S210-S211. doi: 10.1016/j.ijmyco.2016.09.040. Epub 2016 Nov 11.

21.

The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing.

Mortaz E, Alipoor SD, Tabarsi P, Adcock IM, Garssen J, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S184-S185. doi: 10.1016/j.ijmyco.2016.09.045. Epub 2016 Nov 11.

22.

Relation between smear positivity and imaging findings in children with pulmonary tuberculosis.

Hassanzad M, Bolursaz MR, Mehrian P, Aghahosseini F, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S163. doi: 10.1016/j.ijmyco.2016.08.007. Epub 2016 Sep 19.

23.

HIV and tuberculosis trends and survival of coinfection in a referral center in Tehran: A 12-year study.

Baghaei P, Tabarsi P, Jabehdari S, Marjani M, Moniri A, Farnia P, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S16-S17. doi: 10.1016/j.ijmyco.2016.10.010. Epub 2016 Oct 27.

24.

In vitro effects of water-pipe smoke condensate on the endocytic activity of Type II alveolar epithelial cells (A549) with bacillus Calmette-Guérin.

Adcock IM, Mortaz E, Alipoor SD, Garssen J, Akbar Velayati A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S157-S158. doi: 10.1016/j.ijmyco.2016.09.036. Epub 2016 Nov 11.

25.

Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2).

Ghamari E, Farnia P, Saif S, Marashian M, Ghanavi J, Tabarsi P, Farnia P, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S136-S137. doi: 10.1016/j.ijmyco.2016.09.038. Epub 2016 Nov 12.

26.

Yield of mycobacteriological study in diagnosis of pleural tuberculosis among Human immune deficiency virus-infected patients.

Marjani M, Yousefzadeh A, Tabarsi P, Moniri A, Akbar Velayati A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S112-S113. doi: 10.1016/j.ijmyco.2016.09.043. Epub 2016 Nov 11.

27.

Tuberculosis in children.

Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S1-S2. doi: 10.1016/j.ijmyco.2016.10.038. Epub 2016 Nov 23.

28.

Long term outcome of cystic fibrosis patients with multisystem evaluation.

Hassanzad M, Boloursaz MR, Darougar S, Tashayoie Nejad S, Mohajerani SA, Baghaie N, Hashemitari SK, Velayati AA.

Adv Respir Med. 2016;84(6):310-315. doi: 10.5603/ARM.2016.0040.

29.

H1N1 Influenza Patient Saved by Extracorporeal Membrane Oxygenation: First Report from Iran.

Jahangirifard A, Hossein Ahmadi Z, Golestani Eraghi M, Tabarsi P, Marjani M, Moniri A, Nadji SA, Hashemian SM, Velayati AA.

J Tehran Heart Cent. 2016 Jul 6;11(3):153-156.

30.

Radiologic manifestations of pulmonary tuberculosis in patients of intensive care units.

Hashemian SM, Tabarsi P, Karam MB, Kahkouee S, Marjani M, Jamaati H, Shekarchi N, Mohajerani SA, Velayati AA.

Int J Mycobacteriol. 2015 Sep;4(3):233-8. doi: 10.1016/j.ijmyco.2015.05.008. Epub 2015 Jun 19.

31.

Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.

Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.

Arch Virol. 2016 Dec;161(12):3405-3411. Epub 2016 Sep 9.

PMID:
27613286
32.

Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial.

Marjani M, Baghaei P, Kazempour Dizaji M, Gorji Bayani P, Fahimi F, Tabarsi P, Velayati AA.

Iran J Pharm Res. 2016 Winter;15(1):247-52.

33.

Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis.

Baghaei P, Tabarsi P, Javanmard P, Farnia P, Marjani M, Moniri A, Masjedi MR, Velayati AA.

J Glob Antimicrob Resist. 2016 Mar;4:1-4. doi: 10.1016/j.jgar.2015.11.006. Epub 2015 Dec 13.

PMID:
27436384
34.

Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization.

Velayati AA, Abeel T, Shea T, Konstantinovich Zhavnerko G, Birren B, Cassell GH, Earl AM, Hoffner S, Farnia P.

Int J Mycobacteriol. 2016 Mar;5(1):66-73. doi: 10.1016/j.ijmyco.2015.12.001. Epub 2015 Dec 28.

35.

A 14-Year-Old Patient with Chest Pain.

Hassanzad M, Mohajerani SA, Hassanzad N, Velayati AA.

Tanaffos. 2016;15(4):249. No abstract available.

36.

Breathlessness from the Perspective of the Persian Medicine.

Abdolahinia A, Naseri M, Eslaminejad A, Ghaffari F, Velayati AA.

Tanaffos. 2016;15(4):191-196. Review.

37.

Nontuberculous mycobacteria in Middle East: Current situation and future challenges.

Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M.

Int J Mycobacteriol. 2015 Mar;4(1):7-17. doi: 10.1016/j.ijmyco.2014.12.005. Epub 2015 Jan 10. Review.

38.

Role of Innate Lymphoid Cells in Lung Disease.

Marashian SM, Mortaz E, Jamaati HR, Alavi-Moghaddam M, Kiani A, Abedini A, Garssen J, Adcock IM, Velayati AA.

Iran J Allergy Asthma Immunol. 2015 Aug;14(4):346-60. Review.

39.

Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages.

Mortaz E, Adcock IM, Ricciardolo FL, Varahram M, Jamaati H, Velayati AA, Folkerts G, Garssen J.

PLoS One. 2015 Aug 28;10(8):e0136455. doi: 10.1371/journal.pone.0136455. eCollection 2015.

40.

Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance.

Velayati AA, Farnia P, Mozafari M, Mirsaeidi M.

Biomed Res Int. 2015;2015:254285. doi: 10.1155/2015/254285. Epub 2015 May 28. Review.

41.

Impact of HIV infection on tuberculous pleural effusion.

Marjani M, Yousefzadeh A, Baghaei P, Tabarsi P, Moniri A, Masjedi MR, Velayati AA.

Int J STD AIDS. 2016 Apr;27(5):363-9. doi: 10.1177/0956462415581738. Epub 2015 May 8.

PMID:
25957323
42.

Sanctions: Interim initiative for health in Iran.

Velayati AA, Jamaati H, Hashemian SM.

Nature. 2015 May 7;521(7550):32. doi: 10.1038/521032e. No abstract available. Erratum in: Nature. 2015 May 28;521(7553):423.

PMID:
25951274
43.

Response.

Velayati AA, Farnia P, Mirsaeidi M.

Chest. 2015 Apr;147(4):e158-e159. doi: 10.1378/chest.14-3235. No abstract available.

44.

Increased production of soluble vascular endothelial growth factors receptor-1 in CHO-cell line by using new combination of chitosan-protein lipid nanoparticles.

Farnia P, Ghanavi J, Bahrami A, Bandehpour M, Kazemi B, Velayati AA.

Int J Clin Exp Med. 2015 Jan 15;8(1):1526-33. eCollection 2015.

45.

Cotinine level is associated with asthma severity in passive smoker children.

Hassanzad M, Khalilzadeh S, Eslampanah Nobari S, Bloursaz M, Sharifi H, Mohajerani SA, Tashayoie Nejad S, Velayati AA.

Iran J Allergy Asthma Immunol. 2015 Feb;14(1):67-73.

46.

Flow cytometry applications in the study of immunological lung disorders.

Mortaz E, Gudarzi H, Tabarsi P, M Adcock I, Masjedi MR, Jamaati HR, Garssen J, Velayati AA, A Redegeld F.

Iran J Allergy Asthma Immunol. 2015 Feb;14(1):12-8. Review.

47.

Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city.

Velayati AA, Farnia P, Mozafari M, Malekshahian D, Seif S, Rahideh S, Mirsaeidi M.

PLoS One. 2014 Dec 8;9(12):e114428. doi: 10.1371/journal.pone.0114428. eCollection 2014.

48.

Performance of QuantiFERON TB Gold test in detecting latent tuberculosis infection in brain-dead organ donors in Iran: a brief report.

Tabarsi P, Yousefzadeh A, Najafizadeh K, Droudinia A, Bayati R, Marjani M, Shafaghi S, Farokhzad B, Javanmard P, Velayati AA.

Saudi J Kidney Dis Transpl. 2014 Nov;25(6):1240-3.

49.

Estimation of Recent Transmission of Mycobacterium Tuberculosis Strains among Iranian and Afghan Immigrants: A Cluster-Based Study.

Torkaman MR, Nasiri MJ, Farnia P, Shahhosseiny MH, Mozafari M, Velayati AA.

J Clin Diagn Res. 2014 Sep;8(9):DC05-8. doi: 10.7860/JCDR/2014/8886.4864. Epub 2014 Sep 20.

50.

Identification and genotyping of Mycobacterium tuberculosis isolated from water and soil samples of a metropolitan city.

Velayati AA, Farnia P, Mozafari M, Malekshahian D, Farahbod AM, Seif S, Rahideh S, Mirsaeidi M.

Chest. 2015 Apr;147(4):1094-1102. doi: 10.1378/chest.14-0960.

Supplemental Content

Loading ...
Support Center